Sei Investments Co. Has $27.71 Million Holdings in Danaher Co. (DHR)

Sei Investments Co. boosted its stake in Danaher Co. (NYSE:DHR) by 5.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 298,516 shares of the conglomerate’s stock after buying an additional 15,829 shares during the period. Sei Investments Co.’s holdings in Danaher were worth $27,708,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of DHR. Point72 Asset Management L.P. increased its holdings in shares of Danaher by 276.8% during the third quarter. Point72 Asset Management L.P. now owns 2,626,865 shares of the conglomerate’s stock valued at $225,332,000 after purchasing an additional 1,929,751 shares during the period. Arrowstreet Capital Limited Partnership increased its holdings in shares of Danaher by 16,410.0% during the second quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares during the period. Findlay Park Partners LLP increased its holdings in shares of Danaher by 52.9% during the third quarter. Findlay Park Partners LLP now owns 4,117,348 shares of the conglomerate’s stock valued at $353,186,000 after purchasing an additional 1,425,000 shares during the period. Koch Industries Inc. increased its holdings in shares of Danaher by 29,127.3% during the second quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock valued at $1,388,000 after purchasing an additional 1,399,859 shares during the period. Finally, JPMorgan Chase & Co. increased its holdings in shares of Danaher by 86.1% during the third quarter. JPMorgan Chase & Co. now owns 3,011,947 shares of the conglomerate’s stock valued at $256,136,000 after purchasing an additional 1,393,165 shares during the period. 75.88% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Co. (DHR) opened at $97.47 on Friday. Danaher Co. has a 52 week low of $78.97 and a 52 week high of $104.82. The firm has a market capitalization of $66,943.26, a PE ratio of 27.61, a P/E/G ratio of 2.02 and a beta of 1.04. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business had revenue of $5.09 billion during the quarter, compared to analyst estimates of $4.97 billion. During the same quarter last year, the company posted $1.05 EPS. Danaher’s revenue for the quarter was up 10.9% on a year-over-year basis. equities analysts forecast that Danaher Co. will post 4.37 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were given a $0.14 dividend. The ex-dividend date was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.57%. Danaher’s dividend payout ratio (DPR) is 15.86%.

In related news, SVP Angela S. Lalor sold 42,988 shares of the stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total value of $4,397,242.52. Following the completion of the transaction, the senior vice president now owns 82,008 shares in the company, valued at approximately $8,388,598.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP William K. Daniel sold 131,066 shares of the stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $102.05, for a total value of $13,375,285.30. Following the completion of the transaction, the executive vice president now owns 270,523 shares of the company’s stock, valued at approximately $27,606,872.15. The disclosure for this sale can be found here. Insiders sold a total of 237,043 shares of company stock valued at $24,194,886 in the last quarter. 12.20% of the stock is currently owned by corporate insiders.

A number of brokerages have recently commented on DHR. Barclays began coverage on Danaher in a report on Thursday. They set an “overweight” rating and a $110.00 price target on the stock. Credit Suisse Group raised their price target on Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Zacks Investment Research lowered Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Stifel Nicolaus reissued a “buy” rating and set a $110.00 price target on shares of Danaher in a report on Friday, January 19th. Finally, Robert W. Baird reissued a “buy” rating on shares of Danaher in a report on Friday, January 12th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Danaher presently has an average rating of “Buy” and an average target price of $100.68.

COPYRIGHT VIOLATION NOTICE: This piece was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://ledgergazette.com/2018/02/16/sei-investments-co-has-27-71-million-holdings-in-danaher-co-dhr.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply